Effective mitigation of tumor lysis syndrome with gradual venetoclax dose ramp, prophylaxis, and monitoring in patients with chronic lymphocytic leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-016-2695-x
Published Online: 2016-05-14
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seymour, John F.
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2016-05-14